Home Newsletters Cell Therapy News CD3 Engagement as a New Strategy for Allogeneic “Off-the-Shelf” T Cell Therapy

CD3 Engagement as a New Strategy for Allogeneic “Off-the-Shelf” T Cell Therapy

By

-

February 28, 2022

Bi-specific T cell engager (BiTE-T) cells down-regulated CD3ε/TCRαβ on bystander T cells by releasing BiTEs.

[Molecular Therapy-Oncolytics]

6445212 BBBBBBBB items 1 apa 0 default asc 1 172315 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/

Exit mobile version